A case of hyperprogressive disease following atezolizumab therapy for pulmonary pleomorphic carcinoma with epidermal growth factor receptor mutation

Oguri, T; Sasada, S; Seki, S; Murata, S; Tsuchiya, Y; Ishioka, K; Takahashi, S; Seki, R; Hirose, S; Katayama, R; Nakamura, M

Oguri, T (corresponding author), St Marianna Univ, Dept Clin Oncol, Sch Med, Miyamae Ku, 2-16-1 Sugao, Kawasaki, Kanagawa 2158511, Japan.

RESPIRATORY MEDICINE CASE REPORTS, 2021; 33 ():

Abstract

A 66-year old man with non-smoking history was diagnosed with pulmonary pleomorphic carcinoma of the right lower lobe. The carcinoma metastasized to t......

Full Text Link